Tag: biotechnology
-
Carb-X Funds Vaccine Against Resistant Staph Infections
An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities.
-
Multiple Solid-Tumor Immunotherapy Trial Underway
A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs.
-
Microbe Therapy Maker Expands, Adds Venture Funds
A company providing manufacturing services for microbiome drug developers is expanding its facilities, with an infusion of new venture funds.
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Small Biz Grant Funds Hibernating Animal Drug Discovery
A company identifying drug targets from genetic processes in hibernating animals is receiving an NIH grant to advance its technology for heart disease.
-
Gene-Edited Transplant Organ Company Raises $125M
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation.
-
Synthetic RNA Start-Up Gains $80M in Early Funds
A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
ALS Trial Results Deemed Insufficient for FDA Approval
An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use.